|
0
|
|
Early adjunct anti-PD-L1 immunotherapy improves outcomes and restores infection-induced immune paralysis in mice with invasive pulmonary mucormycosis.
(pnas.org)
|
Wurster S
…
Kontoyiannis DP
PNAS
2026-05-26
|
#infection
#immunosuppression
#transcriptomics
#immunotherapy
#fungal
|
|
0
|
|
Enhanced measures of neoantigenicity capture unique tumor-immune interactions across primary melanoma subtypes.
(link.springer.com)
|
Shteinman ER
…
Vergara IA
Genome Medicine
2026-05-26
|
#immunity
#sequencing
#immunotherapy
#melanoma
#neoantigenicity
|
|
0
|
|
Molecular architecture of the tumor microenvironment caused by BRCA1 and BRCA2 somatic mutations in human lung adenocarcinoma.
(elifesciences.org)
|
Liao G
…
Xu G
eLife
2026-05-26
|
#immunity
#transcriptomics
#cancer
#sequencing
#immunotherapy
|
|
0
|
|
A BCG hydrogel enables localized NOD2/STING activation to overcome resistance to immune checkpoint blockade.
(pnas.org)
|
Xiao Z
…
Qiao H
PNAS
2026-05-26
|
#immunity
#cancer
#inflammation
#immunotherapy
#macrophage
|
|
0
|
|
Mucinase-engineered cell membrane nanovesicles degrade the glycocalyx shield to potentiate antitumor immunity.
(pnas.org)
|
Geng X
…
Rao L
PNAS
2026-05-26
|
#cancer
#immunotherapy
#protease
#nanovesicles
#glycocalyx
|
|
0
|
|
NGFR induces melanoma invasion and immunotherapy resistance through myosin light chain 2 modulation.
(link.springer.com)
|
Nogues L
…
Peinado H
The EMBO Journal
2026-05-26
|
#amr
#immunotherapy
#signaling
#melanoma
#invasion
|